allogeneic tumor cell vaccine (PT 107) / Technomark Life Sci, Pique Therapeutics, Inc. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   5 News 
  • ||||||||||  allogeneic tumor cell vaccine (PT 107) / Technomark Life Sciences, Pique Therapeutics, Inc.
    Journal:  Assessment of cardiovascular risk and social framework of Cape Verdean university students studying in Portugal. (Pubmed Central) -  Mar 27, 2019   
    Cape Verdean university students in Portugal (CV-PT) have higher albuminuria, BP and PWV values than PT-PT and CV-CV students, associated with less healthy lifestyles, higher cardiovascular risk and worse socioeconomic conditions. The higher cardiovascular risk in these African immigrants means that it is important to implement measures to address modifiable risk factors, to improve integration and to promote healthy lifestyles.